REQUEST A DEMO
Total
USD $0.00
Search more companies

Glaxosmithkline (Gsk) SRL (Romania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmaceutical and Medicine Manufacturing
Full name: Glaxosmithkline (Gsk) SRL Profile Updated: August 21, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2018 Available in: English & Romanian Download a sample report

GlaxoSmithKline (GSK) was founded on 27 December 2000 by the merger of Glaxo Wellcome and SmithKline Beecham, two renowned pharmaceutical companies, both with long tradition in human health care and pioneering work in many areas of science and medicine. The company produces medicines GMP standards with a portfolio of over 3,400 products. It also markets innovative products in 13 of the major therapeutic areas: respiratory, urology, oncology etc. and by GSK Consumer Healthcare brands sell well-known as Coldrex, Parasinus, Sensodyne, Cetebe

Headquarters
Strada Costache Negri Nr. 1-5
Bucharest; Bucharest; Postal Code: 050552

Contact Details: Purchase the Glaxosmithkline (Gsk) SRL report to view the information.

Website: http://www.gsk.ro

Basic Information
Total Employees:
Purchase the Glaxosmithkline (Gsk) SRL report to view the information.
Registered Capital:
Purchase the Glaxosmithkline (Gsk) SRL report to view the information.
Financial Auditors:
Purchase the Glaxosmithkline (Gsk) SRL report to view the information.
Incorporation Date:
September 08, 1999
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Glaxosmithkline (Gsk) SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
-4.25%
Total operating revenue
-4.21%
Operating profit (EBIT)
-7.33%
EBITDA
-6.9%
Net Profit (Loss) for the Period
17.82%
Total assets
-2.94%
Total equity
4.32%
Operating Profit Margin (ROS)
-0.13%
Net Profit Margin
0.72%
Return on Equity (ROE)
0.2%
Quick Ratio
3.71%
Cash Ratio
2.44%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?